Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01240759 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
A Phase 2 study, sponsored by Shionogi.
- Completed
- Registry status
- Phase 2
- Development phase
- 218
- Enrollment target
NCT01240759 is a Phase 2 study that has completed, run by Shionogi. The registered enrollment target is 218 participants.
The verdict
NCT01240759, a Phase 2 study, has completed, sponsored by Shionogi.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 218 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of S-707106 co-administered with metformin in subjects with type 2 diabetes mellitus.
Interventions
- DRUG Metformin
- DRUG S-707106 Dose A
- DRUG S-707106 Dose B
- DRUG S-707106 Dose C
- DRUG Placebo A tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01240759
The ClinicalTrials.gov registry entry for NCT01240759 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 218 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shionogi, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Metformin is the first listed.
NCT01240759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01240759 about?
NCT01240759 is a clinical study titled "Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy". The purpose of this study is to evaluate the safety and efficacy of S-707106 co-administered with metformin in subjects with type 2 diabetes mellitus.
What is the current status of trial NCT01240759?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 218 participants. The study started on 2010-10. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01240759?
The interventions under investigation include: Metformin (DRUG), S-707106 Dose A (DRUG), S-707106 Dose B (DRUG), S-707106 Dose C (DRUG), Placebo A tablet (DRUG).
Who is sponsoring clinical trial NCT01240759?
This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.